Learn how prostate cancer is treated at each stage, from active surveillance and surgery to radiation, hormone therapy, and targeted drugs.

Researchers have found a potential way to attack prostate cancers that evade treatment by changing their cellular identity.

Combining the targeted therapy olaparib with an additional immunotherapy may improve immune response in a subgroup of ...

Lu-177 vipivotide tetraxetan shifted from post-taxane mCRPC to pre-chemotherapy mCRPC and then metastatic hormone-sensitive ...

Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they need to grow. Weill Cornell ...

Over the past year alone, 4 major clinical trials have redefined frontline HSPC management. ARANOTE ( NCT02799602) v alidated ...

Why doesn’t my doctor automatically order a PSA test to screen for prostate cancer? Shouldn’t all men be tested regularly? With over 330,000 new cases estimated for 2026, prostate cancer accounts for ...

Manojkumar Bupathi, MD, MS, discusses the changes that biomarker-based treatment brings to hormone-sensitive prostate cancer.

Scott Ford’s experience at NYU Langone Hospital—Long Island highlights how targeted radiation can help some men stay active ...

In "Beyond Diagnosis: Metastatic Castration-Sensitive Prostate Cancer," Cleveland Clinic oncologist Christopher Wee, MD, and ...

Approximately 40% of men with prostate cancer treated with concurrent androgen deprivation therapy and androgen receptor pathway inhibitors may develop metabolic syndrome within a year.A retrospective ...

Many prostate cancers depend on androgen hormones, including testosterone, to grow. That is why treatments for advanced disease often try to reduce testosterone production or block its effects. Now, ...